Systemic therapy and novel agents for metastatic castration resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic therapy and novel agents for metastatic castration resistant prostate cancer

Published:2009-04 Issue:3 Volume:3 Page:133-145
ISSN:1872-115X
Container-title:Update on Cancer Therapeutics
language:en
Short-container-title:Update on Cancer Therapeutics

Author:

Fleming Mark T.,Sonpavde Guru,Kondagunta G. Varuni,Galsky Matthew D.,Hutson Thomas E.,Sternberg Cora N.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference122 articles.

1. Cancer Statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Androgen deprivation therapy for prostate cancer;Singer;Expert Opin Pharmacother,2008

3. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points;Tannock;J Clin Oncol,1996

4. Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the Cancer and Leukemia Group B 9182 Study;Kantoff;J Clin Oncol,1999

5. Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer;Berry;J Urol,2002

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redefining hormone resistance in prostate cancer;Therapeutic Advances in Medical Oncology;2009-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP